Home » Topics » Regulatory » EMA

EMA
RSS

EMA launches improved version of EudraVigilance system for safety monitoring

Nov. 22, 2017

EMA announces relocation to the Netherlands

Nov. 21, 2017

Orexo's Zubsolv approved for opioid dependence in Europe

Nov. 21, 2017

bb-2121 receives FDA breakthrough therapy and EMA PRIME designations

Nov. 17, 2017

Marketing applications for volanesorsen accepted in U.S., E.U. and Canada

Nov. 16, 2017

EMA grants Motrem access to PRIME scheme for septic shock

Nov. 15, 2017

EMA's CHMP issues positive opinion on Adcetris for CTCL

Nov. 15, 2017

EMA committee supports approval of Endoceutics' Intrarosa

Nov. 15, 2017

EMA grants accelerated assessment to patisiran for hereditary ATTR amyloidosis

Nov. 14, 2017

EMA grants orphan drug designation to Debio-1347

Nov. 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...